Can neuroimaging predict dementia in Parkinson's disease?
- PMID: 30137209
- PMCID: PMC6113860
- DOI: 10.1093/brain/awy211
Can neuroimaging predict dementia in Parkinson's disease?
Abstract
Dementia in Parkinson's disease affects 50% of patients within 10 years of diagnosis but there is wide variation in severity and timing. Thus, robust neuroimaging prediction of cognitive involvement in Parkinson's disease is important: (i) to identify at-risk individuals for clinical trials of potential new treatments; (ii) to provide reliable prognostic information for individuals and populations; and (iii) to shed light on the pathophysiological processes underpinning Parkinson's disease dementia. To date, neuroimaging has not made major contributions to predicting cognitive involvement in Parkinson's disease. This is perhaps unsurprising considering conventional methods rely on macroscopic measures of topographically distributed neurodegeneration, a relatively late event in Parkinson's dementia. However, new technologies are now emerging that could provide important insights through detection of other potentially relevant processes. For example, novel MRI approaches can quantify magnetic susceptibility as a surrogate for tissue iron content, and increasingly powerful mathematical approaches can characterize the topology of brain networks at the systems level. Here, we present an up-to-date overview of the growing role of neuroimaging in predicting dementia in Parkinson's disease. We discuss the most relevant findings to date, and consider the potential of emerging technologies to detect the earliest signs of cognitive involvement in Parkinson's disease.
Figures


Similar articles
-
Parkinson's disease dementia: a neural networks perspective.Brain. 2015 Jun;138(Pt 6):1454-76. doi: 10.1093/brain/awv104. Epub 2015 Apr 16. Brain. 2015. PMID: 25888551 Free PMC article. Review.
-
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.Brain. 2014 Oct;137(Pt 10):2743-58. doi: 10.1093/brain/awu201. Epub 2014 Jul 30. Brain. 2014. PMID: 25080285 Free PMC article.
-
Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.Brain. 2014 Aug;137(Pt 8):2356-67. doi: 10.1093/brain/awu159. Epub 2014 Jun 20. Brain. 2014. PMID: 24951642 Free PMC article.
-
Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis.Brain Imaging Behav. 2019 Aug;13(4):1021-1034. doi: 10.1007/s11682-018-9922-0. Brain Imaging Behav. 2019. PMID: 29971686
-
Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease.Parkinsonism Relat Disord. 2015 Aug;21(8):862-70. doi: 10.1016/j.parkreldis.2015.05.013. Epub 2015 May 19. Parkinsonism Relat Disord. 2015. PMID: 26004683 Review.
Cited by
-
Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson's Disease.Front Neurosci. 2021 Sep 20;15:665820. doi: 10.3389/fnins.2021.665820. eCollection 2021. Front Neurosci. 2021. PMID: 34616271 Free PMC article. Review.
-
Sequence of clinical and neurodegeneration events in Parkinson's disease progression.Brain. 2021 Apr 12;144(3):975-988. doi: 10.1093/brain/awaa461. Brain. 2021. PMID: 33543247 Free PMC article.
-
Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways.CNS Drugs. 2019 Feb;33(2):143-160. doi: 10.1007/s40263-018-0601-x. CNS Drugs. 2019. PMID: 30687888 Free PMC article. Review.
-
Parkinson disease-associated cognitive impairment.Nat Rev Dis Primers. 2021 Jul 1;7(1):47. doi: 10.1038/s41572-021-00280-3. Nat Rev Dis Primers. 2021. PMID: 34210995 Review.
-
Orthostatic hypotension in dementia with Lewy bodies: a meta-analysis of prospective studies.Clin Auton Res. 2023 Apr;33(2):133-141. doi: 10.1007/s10286-023-00933-1. Epub 2023 Mar 2. Clin Auton Res. 2023. PMID: 36862320 Review.
References
-
- Aarsland D, Brønnick K, Larsen JP, Tysnes OB, Alves G. Cognitive impairment in incident, untreated parkinson disease: the norwegian parkwest study. Neurology 2009; 72: 1121–26. - PubMed
-
- Acosta-Cabronero J, Cardenas-Blanco A, Betts MJ, Butryn M, Valdes-Herrera JP, Galazky I et al. . The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease. Brain 2016; 140: 118–31. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical